Christopher Silber's most recent trade in Vigil Neuroscience Inc was a trade of 330,000 Stock Option Grant (Right to Buy) done . Disclosure was reported to the exchange on Aug. 7, 2023.
| Stock | Client Name | Client Category | Action | Reported to Exchange | Quantity | Post Transaction Holding | Traded % | Avg. Price | Value | Security Type |
|---|---|---|---|---|---|---|---|---|---|---|
| Vigil Neuroscience Inc | Christopher Silber | Chief Medical Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 07 Aug 2023 | 330,000 | 330,000 | - | - | Stock Option Grant (Right to Buy) |